Bausch Health Companies | VRX - Stock



Bausch Health Companies reported $1.66B in Stock for its fiscal quarter ending in June of 2025.


Stock Change Date
Amgen USD 6.58B 146M Jun/2025
ANI Pharmaceuticals USD 138.32M 907K Jun/2025
Aurora Cannabis CAD 228.26M 25.75M Jun/2025
Bausch Health Companies USD 1.66B 42M Jun/2025
Biogen USD 2.27B 400K Jun/2025
Bristol-Myers Squibb USD 2.74B 71M Jun/2025
Canopy Growth CAD 93.82M 3.07M Jun/2025
Corcept Therapeutics USD 12.28M 3.26M Jun/2025
Danaher USD 2.69B 157M Jun/2025
Drreddys Laboratories 75.6B 3.97B Jun/2025
Eli Lilly USD 11.01B 1.7B Jun/2025
Gilead Sciences USD 1.83B 66M Jun/2025
Novo Nordisk 45.65B 21.26B Jun/2025
Pacira USD 148.16M 14.41M Jun/2025
Perrigo USD 1.22B 60.5M Jun/2025
Prestige Brands USD 153.13M 5.42M Jun/2025
Supernus Pharmaceuticals USD 44.02M 5.4M Jun/2025
Vertex Pharmaceuticals USD 1.5B 139.6M Jun/2025
Zoetis USD 2.44B 74M Jun/2025